glp-1 discontinuation Patients with diabetes who remained on drugs had lower cardiovascular risk New Truveta study highlights patterns
Description
This session will focus on the convergence of food and pharma, which joins a sister trend in health/care: food-as-medicine
Is there a more American way to get 10k steps
Throwing up on a GLP-1

The molecular mechanisms of the neuroprotective effects of GLP-1 RA in diabetes-related degenerative diseases, including AD and PD, and their potential effects.

Manuel Cornely (Germany) come together to share their clinical experiences treating lipedema patients with GLP-1 RA medications such as Liraglutide (Saxenda) and Semaglutide (Wegovy)
